Nuklearmedizin 2015; 54(03): 101-105
DOI: 10.1055/s-0037-1616609
Innovation Schilddrüse
Schattauer GmbH

Is thyroid surgery performed too often in Germany?

Wird die Schilddrüse in Deutschland zu oft operiert?
F. A. Verburg
1   Department of Nuclear Medicine, RWTH University Hospital Aachen, Germany
2   Department of Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands
› Author Affiliations
Further Information

Publication History

received: 17 September 2014

accepted: 20 May 2015

Publication Date:
11 January 2018 (online)

Summary

Thyroid surgery is one of the more common surgical procedures in Germany. This is in contrast with the situation in some other countries, where this procedure is performed comparatively rarely. In this paper the number of thyroid surgeries in Germany is compared with other western countries (Netherlands, USA, England). In contrast to e. g. the USA and England the number of thyroid surgeries in Germany is declining, however with approximately 109/100 000/year in 2012 is still elevated (Netherlands: 16/100 000/year, USA: at least 42/100 000/year, England: at least 27/100 000/year).

Possible contributing factors to this higher number of thyroid surgeries in Germany are explored. These factors include iodine deficiency, the frequent use of advanced diagnostics such as ultrasound, insufficient use of preoperative diagnostic measures such as fine needle biopsy and the practice of “defensive medicine”. How much each of these factors contributes is however unclear.

Zusammenfassung

In Gegensatz zu anderen Ländern, wo die Prozedur relativ selten erfolgt, zählen Schilddrüsenoperation zu den am häufigsten Operationen in Deutschland. In diesem Artikel wird die Zahl der Schilddrüsenoperationen in Deutschland verglichen mit der Zahl in einigen anderen westlichen Ländern (Niederlande, USA, England). In Gegensatz zu der USA und England nimmt die Zahl der jährlich in Deutschland durchgeführten Schilddrüsenoperation ab, jedoch ist sie mit 109/100 000/Jahr im internationalen Vergleich deutlich erhöht (Niederlande: 16/100 000/Jahr, USA: mindestens 42/100 000/Jahr, England: mindestens 27/100 000/Jahr)

Zu den Faktoren, die an dieser erhöhten Zahl beitragen, zählen Iodmangel, der häufige Einsatz hochkomplexer Diagnostik (z. B. Ultraschall), die nicht ausreichende Benutzung präoperativer Diagnostik (Z.B. Feinnadelbiopsie) und das Betreiben “defensiver” Medizin. Es kann nicht abgeschätzt werden, in welchem Ausmaß jeder dieser Faktoren an der höheren Operationszahl beiträgt.

 
  • References

  • 1 Fallpauschalenbezogene Krankenhausstatistik (DRG-Statistik) Operation und Prozeduren der vollstationären Patientinnen und Patienten in Krankenhäusern - Ausführliche Darstellung - 2008. Wiesbaden: Statistisches Bundesamt; 2009
  • 2 Hospital Episode Statistics for England. Inpatient statistics, 2011-12 Summary Report. Leeds: Health & Social Care Information Centre; 2012
  • 3 Krebs in Deutschland 2007/2008. 8. Ausgabe Berlin: Robert Koch-Institut; 2012
  • 4 Fallpauschalenbezogene Krankenhausstatistik (DRG-Statistik) Operationen und Prozeduren der vollstationären Patientinnen und Patienten in Krankenhäusern - Ausführliche Darstellung - 2012. Wiesbaden: Statistisches Bundesamt; 2013
  • 5 SEER Cancer Statistics Review, 1975-2011. Bethesda, MD: National Cancer Institute; 2014
  • 6 Berghout A, Hoogendoorn D, Wiersinga WM. A diminishing number of thyroid operations in The Netherlands in 1972-1986. Ned Tijdschr Geneeskd 1989; 133: 1313-1317.
  • 7 Dean DS, Gharib H. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab 2008; 22: 901-911.
  • 8 Dralle H, Stang A, Sekulla C, Rusner C, Lorenz K, Machens A. Surgery for benign goiter in Germany: fewer operations, changed resectional strategy, fewer complications. Chirurg 2014; 85: 236-245.
  • 9 Gelsema T, De Bruin A. Operaties in het Ziekenhuis. Mogelijkheden van verrichtingencijfers op basis van Diagnose Behandel Combinaties. Den Haag/Heerlen: Centraal Bureau voor de Statistiek; 2012
  • 10 Gutekunst R, Magiera U, Teichert HM. Iodine deficiency in Germany. Med Klin (Munich) 1993; 88: 525-528.
  • 11 Hampel R, Bennohr G, Gordalla A, Below H. Urinary iodide excretion in adults in germany 2005 meets WHO target. Exp Clin Endocrinol Diabetes 2010; 118: 254-257.
  • 12 Husson O, Haak HR, van Steenbergen LN, Nieuwlaat WA. et al. Rising incidence, no change in survival and decreasing mortality from thyroid cancer in The Netherlands since 1989. Endocr Relat Cancer 2013; 20: 263-271.
  • 13 Lee TJ, Kim S, Cho HJ, Lee JH. The incidence of thyroid cancer is affected by the characteristics of a healthcare system. J Korean Med Sci 2012; 27: 1491-1498.
  • 14 Luster M, Verburg FA, Scheidhauer K. Diagnostic imaging work up in multi-nodular goiter. Minerva Endocrinol 2010; 35: 153-159.
  • 15 Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993; 328: 553-559.
  • 16 Musholt TJ, Clerici T, Dralle H. et al. German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease. Langenbecks Arch Surg 2011; 396: 639-649.
  • 17 Reiners C, Wegscheider K, Schicha H. et al. Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 2004; 14: 926-932.
  • 18 Sosa JA, Hanna JW, Robinson KA, Lanman RB. Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. Surgery 2013; 154: 1420-1426.
  • 19 Thomusch O, Machens A, Sekulla C. et al. Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany. World J Surg 2000; 24: 1335-1341.
  • 20 Ting S, Bockisch A, Führer D. et al. Feinnadelbiopsie (FNB) der Schilddrüse. Nuklearmediziner 2012; 35: 22-29.
  • 21 Udelsman R, Zhang Y. The epidemic of thyroid cancer in the United States: The role of endocrinologists and ultrasounds. Thyroid 2014; 24: 472-479.
  • 22 Verburg FA, Behrendt FF, Mottaghy FM, Heinzel A. Cost-effectiveness of 99mTc-MIBI in the evaluation of thyroid nodules for malignancy: a new lease of life for an old radiopharmaceutical?. Eur J Nucl Med Mol Imaging 2014; 41: 102-104.
  • 23 Wale A, Miles KA, Young B. et al. Combined 99mTc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules. Eur J Nucl Med Mol Imaging 2014; 41: 105-115.